Gaush Meditech Future Growth
Future criteria checks 4/6
Gaush Meditech is forecast to grow earnings and revenue by 23.6% and 13.2% per annum respectively. EPS is expected to grow by 23.5% per annum. Return on equity is forecast to be 15.2% in 3 years.
Key information
23.6%
Earnings growth rate
23.5%
EPS growth rate
Medical Equipment earnings growth | 34.8% |
Revenue growth rate | 13.2% |
Future return on equity | 15.2% |
Analyst coverage | Low |
Last updated | 05 May 2024 |
Recent future growth updates
No updates
Recent updates
Revenues Working Against Gaush Meditech Ltd's (HKG:2407) Share Price Following 25% Dive
Apr 05Estimating The Intrinsic Value Of Gaush Meditech Ltd (HKG:2407)
Dec 07A Look At The Fair Value Of Gaush Meditech Ltd (HKG:2407)
Aug 08Gaush Meditech Ltd's (HKG:2407) Business And Shares Still Trailing The Industry
Jun 01Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,092 | 365 | N/A | N/A | 1 |
12/31/2025 | 1,843 | 303 | N/A | N/A | 1 |
12/31/2024 | 1,611 | 239 | N/A | N/A | 1 |
12/31/2023 | 1,406 | 174 | N/A | N/A | N/A |
9/30/2023 | 1,391 | -7 | N/A | N/A | N/A |
6/30/2023 | 1,377 | -187 | 229 | 270 | N/A |
3/31/2023 | 1,315 | -268 | 208 | 252 | N/A |
12/31/2022 | 1,254 | -350 | 186 | 234 | N/A |
9/30/2022 | 1,276 | -278 | 188 | 230 | N/A |
6/30/2022 | 1,298 | -207 | 189 | 226 | N/A |
3/31/2022 | 1,298 | -199 | 163 | 195 | N/A |
12/31/2021 | 1,298 | -190 | 136 | 164 | N/A |
12/31/2020 | 962 | 99 | 128 | 130 | N/A |
12/31/2019 | 1,107 | -37 | 167 | 171 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2407's forecast earnings growth (23.6% per year) is above the savings rate (2.2%).
Earnings vs Market: 2407's earnings (23.6% per year) are forecast to grow faster than the Hong Kong market (12% per year).
High Growth Earnings: 2407's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2407's revenue (13.2% per year) is forecast to grow faster than the Hong Kong market (8% per year).
High Growth Revenue: 2407's revenue (13.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2407's Return on Equity is forecast to be low in 3 years time (15.2%).